Acer Therapeutics Inc. (NASDAQ: ACER) shares jumped more than 10% after the Company announced together with its collaboration partner, RELIEF THERAPEUTICS Holding SA, that the China National Intellectual Property Administration (CNIPA) issued Electronic Patent Certificate ZL202122004991.9 on May 24, 2022,...
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) share up more than 86% after the Company announced the development of the HYLA™ blood sensor. Without the...
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) has reported results from its biomarker study conducted to evaluate the potential CogniC, NeuroSense’s drug for treatment of Alzheimer’s disease....
Hillstream BioPharma, Inc. (Nasdaq: HILS) today announced that it has begun a collaboration with Sapien Biosciences to evaluate the synergy of HSB-1216 with immune checkpoint...
F-star Therapeutics, Inc. (NASDAQ: FSTX) has announced that invoX Pharma, subsidiary of Sino Biopharm has plans to acquire the company for USD 7.12 per share. ...
uniQure N.V. (NASDAQ: QURE) share up more than 15% after the Company announced on Thursday new safety and biomarker data from 10 patients enrolled in...
OneWater Marine Inc. (NASDAQ: ONEW) today announced that it has signed a definitive agreement to acquire Ocean Bio-Chem, Inc. Up Premarket OneWater Marine Inc. (NASDAQ:...
Moderna, Inc. (NSDAQ: MRNA) has reported new clinical data on Omicron bivalent COVID booster candidate, MRNA-1273.214 and a vaccine candidate targeting the Omicron variant in...
JanOne Inc. (NASDAQ: JAN) shares spike more than 50% on Tuesday after the company announced that a patent was issued that covers a method of...
Yumanity Therapeutics, Inc. (Nasdaq: YMTX) today announced that it has entered into definitive agreements for two strategic transactions. Up Over 46% Shares of Yumanity Therapeutics,...
Futu Holdings Limited (NASDAQ: FUTU) shares jumped more than 20% after the Company announced solid performance for the quarter ended March 31, 2022, with US$209.5...
Bristol Myers Squibb (NYSE: BMY) and Turning Point therapeutics, Inc. (NASDAQ: TPTX) has announced a definitive merger agreement under which Bristol Myers Squibb will acquire...
Sprague Resources LP (NYSE: SRLP) reported on Friday that it has entered into a definitive agreement and plan of merger pursuant to which an affiliate...
Jul 8, 2022 by MarketDepth